These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 18410929)
21. Monoclonal antibody-based localization of major diagnostic antigens in metacestode tissue, excretory/secretory products, and extracellular vesicles of Kronenberg PA; Reinehr M; Eichenberger RM; Hasler S; Laurimäe T; Weber A; Deibel A; Müllhaupt B; Gottstein B; Müller N; Hemphill A; Deplazes P Front Cell Infect Microbiol; 2023; 13():1162530. PubMed ID: 37009502 [TBL] [Abstract][Full Text] [Related]
22. Dual Role of Hepatic Macrophages in the Establishment of the Wang H; Zhang CS; Fang BB; Hou J; Li WD; Li ZD; Li L; Bi XJ; Li L; Abulizi A; Shao YM; Lin RY; Wen H Front Immunol; 2020; 11():600635. PubMed ID: 33488594 [No Abstract] [Full Text] [Related]
23. In vitro culture of Echinococcus multilocularis and Echinococcus vogeli metacestodes: studies on the host-parasite interface. Hemphill A; Stettler M; Walker M; Siles-Lucas M; Fink R; Gottstein B Acta Trop; 2003 Feb; 85(2):145-55. PubMed ID: 12606091 [TBL] [Abstract][Full Text] [Related]
24. Echinococcus multilocularis: immunological study on the "Em2-positive" laminated layer during in vitro and in vivo post-oncospheral and larval development. Gottstein B; Deplazes P; Aubert M Parasitol Res; 1992; 78(4):291-7. PubMed ID: 1409528 [TBL] [Abstract][Full Text] [Related]
25. Serological diagnosis of echinococcosis: the diagnostic potential of native antigens. Schweiger A; Grimm F; Tanner I; Müllhaupt B; Bertogg K; Müller N; Deplazes P Infection; 2012 Apr; 40(2):139-52. PubMed ID: 22076692 [TBL] [Abstract][Full Text] [Related]
26. In vitro metabolomic footprint of the Echinococcus multilocularis metacestode. Ritler D; Rufener R; Li JV; Kämpfer U; Müller J; Bühr C; Schürch S; Lundström-Stadelmann B Sci Rep; 2019 Dec; 9(1):19438. PubMed ID: 31857639 [TBL] [Abstract][Full Text] [Related]
27. The Echinococcus multilocularis 14-3-3 protein protects mice against primary but not secondary alveolar echinococcosis. Siles-Lucas M; Merli M; Mackenstedt U; Gottstein B Vaccine; 2003 Jan; 21(5-6):431-9. PubMed ID: 12531641 [TBL] [Abstract][Full Text] [Related]
28. Characterization of a surface glycoprotein from Echinococcus multilocularis and its mucosal vaccine potential in dogs. Kouguchi H; Matsumoto J; Nakao R; Yamano K; Oku Y; Yagi K PLoS One; 2013; 8(7):e69821. PubMed ID: 23894545 [TBL] [Abstract][Full Text] [Related]
29. Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease. Huang X; Grüner B; Lechner CJ; Kern P; Soboslay PT Med Microbiol Immunol; 2014 Jun; 203(3):185-93. PubMed ID: 24509604 [TBL] [Abstract][Full Text] [Related]
30. Depletion of FoxP3 Wang J; Müller S; Lin R; Siffert M; Vuitton DA; Wen H; Gottstein B Immun Inflamm Dis; 2017 Dec; 5(4):435-447. PubMed ID: 28621034 [TBL] [Abstract][Full Text] [Related]
31. Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice. Wang J; Vuitton DA; Müller N; Hemphill A; Spiliotis M; Blagosklonov O; Grandgirard D; Leib SL; Shalev I; Levy G; Lu X; Lin R; Wen H; Gottstein B PLoS Negl Trop Dis; 2015 May; 9(5):e0003755. PubMed ID: 25955764 [TBL] [Abstract][Full Text] [Related]
32. Characterization of microRNAs expressed in the cystic legion of the liver of Mus musculus perorally infected with Echinococcus multilocularis Nemuro strain. Imasato Y; Nakao R; Irie T; Kouguchi H; Yagi K; Nariaki N; Katakura K Parasitol Int; 2021 Apr; 81():102247. PubMed ID: 33238214 [TBL] [Abstract][Full Text] [Related]
33. Expression profiling of Echinococcus multilocularis miRNAs throughout metacestode development in vitro. Macchiaroli N; Preza M; Pérez MG; Kamenetzky L; Cucher M; Koziol U; Castillo E; Berriman M; Brehm K; Rosenzvit MC PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009297. PubMed ID: 33750964 [TBL] [Abstract][Full Text] [Related]
34. Immunotherapy of alveolar echinococcosis via PD-1/PD-L1 immune checkpoint blockade in mice. Wang J; Jebbawi F; Bellanger AP; Beldi G; Millon L; Gottstein B Parasite Immunol; 2018 Dec; 40(12):e12596. PubMed ID: 30315719 [TBL] [Abstract][Full Text] [Related]
35. Enhancing the therapeutic potential of P29 protein-targeted monoclonal antibodies in the management of alveolar echinococcosis through CDC-mediated mechanisms. Zhang C; Li T; Hou S; Tang J; Wen R; Wang C; Yuan S; Li Z; Zhao W PLoS Pathog; 2024 Aug; 20(8):e1012479. PubMed ID: 39178325 [TBL] [Abstract][Full Text] [Related]
36. An Echinococcus multilocularis Antigen B3 Proteoform That Shows Specific Antibody Responses to Active-Stage Alveolar Echinococcosis. Ahn CS; Cai H; Kim JG; Han X; Ma X; Bae YA; Yang HJ; Kang I; Wang H; Kong Y J Clin Microbiol; 2015 Oct; 53(10):3310-7. PubMed ID: 26269620 [TBL] [Abstract][Full Text] [Related]
38. Transient transfection of Echinococcus multilocularis primary cells and complete in vitro regeneration of metacestode vesicles. Spiliotis M; Lechner S; Tappe D; Scheller C; Krohne G; Brehm K Int J Parasitol; 2008 Jul; 38(8-9):1025-39. PubMed ID: 18086473 [TBL] [Abstract][Full Text] [Related]
39. Triggering and modulation of the host-parasite interplay by Echinococcus multilocularis: a review. Mejri N; Hemphill A; Gottstein B Parasitology; 2010 Mar; 137(3):557-68. PubMed ID: 19961650 [TBL] [Abstract][Full Text] [Related]
40. Primary alveolar echinococcosis: course of larval development and antibody responses in intermediate host rodents with different genetic backgrounds after oral infection with eggs of Echinococcus multilocularis. Matsumoto J; Kouguchi H; Oku Y; Yagi K Parasitol Int; 2010 Sep; 59(3):435-44. PubMed ID: 20601109 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]